Pricing Log in Create free account
Friday 6 November 2026 Export CAH’s income statement to Excel — free account

Cardinal Health, Inc.

CAH Healthcare Medical Distribution

Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025.

Revenue
+5.47%
EPS
+26.3%
Free cash flow
+10.9%
Total debt
−2.40%

Quarter to September 2026, against a year earlier

267.66 5.73 +2.19%
Market cap
$62.0B
P/E
34.5×
Fwd P/E
24.5×
Dividend yield
0.77%
F-score
7/9
Altman Z
5.09
Beneish M
−2.74
Dividend safety
86/100
Overview Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Cardinal Health, Inc. (CAH) SEC filings, changes and red flags

Red flags

  • Impairment

    Cardinal Health, Inc. recorded a goodwill impairment of $184.0 million in fiscal 2026

    10-K filed · The filing · sec.gov

  • Officer departure

    Cardinal Health, Inc. reported the departure of an officer or director

    8-K filed · The filing · sec.gov

  • Restatement

    Cardinal Health, Inc.’s 10-K corrects an error in previously issued financial statements

    10-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Nov 5, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Oct 1, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Jun 30, 2026 1: no comparison — the Item was not found
1A: no comparison — the Item was not found
7: no comparison — the Item was not found 		Impairment
8-K Aug 11, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 7, 2026 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Aug 4, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-Q Mar 31, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Apr 30, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 17, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 2, 2026 5.02 Departure or appointment of directors or officers
10-Q Dec 31, 2025
8-K Feb 5, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 13, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Nov 5, 2025 5.07 Submission of matters to a vote of security holders
10-Q Sep 30, 2025
8-K Oct 30, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Oct 7, 2025 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Sep 30, 2025 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Aug 27, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-K Jun 30, 2025
8-K Aug 12, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 1, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Dec 31, 2024
8-K Jan 30, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 1, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Jun 30, 2024 Restatement
8-K Aug 14, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 2, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Feb 1, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 9, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.